APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artificial Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Artificial Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173967450330 December 2025189 pages

Choose your research edition.

Industry ResearchArtificial Blood Products Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Blood Products Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Artificial Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Blood Products Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Blood Products Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Artificial Blood Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Artificial Blood Products include SpheriTech Ltd., NuvOx Pharma, KaloCyte Inc., HEMARINA SA, HbO2 Therapeutics and Aurum Biosciences Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Artificial Blood Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Blood Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Blood Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Blood Products Segment by Company

SpheriTech Ltd.

NuvOx Pharma

KaloCyte Inc.

HEMARINA SA

HbO2 Therapeutics

Aurum Biosciences Ltd.

Artificial Blood Products Segment by Type

Perfluorocarbon-based Oxygen Carrier (PFBOC)

Hemoglobin-based Oxygen Carrier (HBOC)

Artificial Blood Products Segment by Application

Military

Civil

Artificial Blood Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Blood Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artificial Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Artificial Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Artificial Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Artificial Blood Products Industry Trends Table 2. Artificial Blood Products Industry Drivers Table 3. Artificial Blood Products Industry Opportunities and Challenges Table 4. Artificial Blood Products Industry Restraints Table 5. Global Artificial Blood Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Artificial Blood Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Artificial Blood Products Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Artificial Blood Products Sales Market Share by Manufacturers Table 9. Global Artificial Blood Products Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Artificial Blood Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Artificial Blood Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Artificial Blood Products Manufacturers, Product Type & Application Table 13. Global Artificial Blood Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Artificial Blood Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Perfluorocarbon-based Oxygen Carrier (PFBOC) Table 17. Major Manufacturers of Hemoglobin-based Oxygen Carrier (HBOC) Table 18. Global Artificial Blood Products Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 20. Global Artificial Blood Products Sales by Type (2027-2032) & (K Units) Table 21. Global Artificial Blood Products Sales Market Share by Type (2021-2026) Table 22. Global Artificial Blood Products Sales Market Share by Type (2027-2032) Table 23. Global Artificial Blood Products Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Artificial Blood Products Revenue by Type (2021-2026) & (K Units) Table 25. Global Artificial Blood Products Revenue by Type (2027-2032) & (K Units) Table 26. Global Artificial Blood Products Revenue Market Share by Type (2021-2026) Table 27. Global Artificial Blood Products Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Military Table 29. Major Manufacturers of Civil Table 30. Global Artificial Blood Products Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 32. Global Artificial Blood Products Sales by Application (2027-2032) & (K Units) Table 33. Global Artificial Blood Products Sales Market Share by Application (2021-2026) Table 34. Global Artificial Blood Products Sales Market Share by Application (2027-2032) Table 35. Global Artificial Blood Products Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Artificial Blood Products Revenue by Application (2021-2026) & (K Units) Table 37. Global Artificial Blood Products Revenue by Application (2027-2032) & (K Units) Table 38. Global Artificial Blood Products Revenue Market Share by Application (2021-2026) Table 39. Global Artificial Blood Products Revenue Market Share by Application (2027-2032) Table 40. Global Artificial Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Artificial Blood Products Sales by Region (2021-2026) & (K Units) Table 42. Global Artificial Blood Products Sales Market Share by Region (2021-2026) Table 43. Global Artificial Blood Products Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Artificial Blood Products Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Artificial Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 47. North America Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 48. Europe Artificial Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 50. Europe Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Artificial Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Artificial Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 57. Global Artificial Blood Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Artificial Blood Products Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Artificial Blood Products Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Artificial Blood Products Revenue Market Share by Region (2021-2026) Table 61. Global Artificial Blood Products Revenue Market Share by Region (2027-2032) Table 62. SpheriTech Ltd. Company Information Table 63. SpheriTech Ltd. Business Overview Table 64. SpheriTech Ltd. Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. SpheriTech Ltd. Artificial Blood Products Product Portfolio Table 66. SpheriTech Ltd. Recent Development Table 67. NuvOx Pharma Company Information Table 68. NuvOx Pharma Business Overview Table 69. NuvOx Pharma Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. NuvOx Pharma Artificial Blood Products Product Portfolio Table 71. NuvOx Pharma Recent Development Table 72. KaloCyte Inc. Company Information Table 73. KaloCyte Inc. Business Overview Table 74. KaloCyte Inc. Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. KaloCyte Inc. Artificial Blood Products Product Portfolio Table 76. KaloCyte Inc. Recent Development Table 77. HEMARINA SA Company Information Table 78. HEMARINA SA Business Overview Table 79. HEMARINA SA Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. HEMARINA SA Artificial Blood Products Product Portfolio Table 81. HEMARINA SA Recent Development Table 82. HbO2 Therapeutics Company Information Table 83. HbO2 Therapeutics Business Overview Table 84. HbO2 Therapeutics Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. HbO2 Therapeutics Artificial Blood Products Product Portfolio Table 86. HbO2 Therapeutics Recent Development Table 87. Aurum Biosciences Ltd. Company Information Table 88. Aurum Biosciences Ltd. Business Overview Table 89. Aurum Biosciences Ltd. Artificial Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio Table 91. Aurum Biosciences Ltd. Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Artificial Blood Products Distributors List Table 95. Artificial Blood Products Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Artificial Blood Products Product Image Figure 2. Global Artificial Blood Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Blood Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Blood Products Sales (2021-2032) & (K Units) Figure 5. Global Artificial Blood Products Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Artificial Blood Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Perfluorocarbon-based Oxygen Carrier (PFBOC) Image Figure 9. Hemoglobin-based Oxygen Carrier (HBOC) Image Figure 10. Global Artificial Blood Products Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Artificial Blood Products Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Artificial Blood Products Sales Market Share by Type (2021-2032) Figure 13. Global Artificial Blood Products Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Artificial Blood Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Artificial Blood Products Revenue Market Share by Type (2021-2032) Figure 16. Military Image Figure 17. Civil Image Figure 18. Global Artificial Blood Products Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Artificial Blood Products Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Artificial Blood Products Sales Market Share by Application (2021-2032) Figure 21. Global Artificial Blood Products Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Artificial Blood Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Artificial Blood Products Revenue Market Share by Application (2021-2032) Figure 24. North America Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Artificial Blood Products Sales Market Share by Country (2021-2032) Figure 26. U.S. Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Artificial Blood Products Sales Market Share by Country (2021-2032) Figure 31. Germany Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Artificial Blood Products Sales Market Share by Country (2021-2032) Figure 38. China Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Artificial Blood Products Sales Market Share by Country (2021-2032) Figure 46. Brazil Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Artificial Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Artificial Blood Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Artificial Blood Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Artificial Blood Products Revenue (2021-2032) & (US$ Million) Figure 57. North America Artificial Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Artificial Blood Products Revenue (2021-2032) & (US$ Million) Figure 59. Europe Artificial Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Artificial Blood Products Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Artificial Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Artificial Blood Products Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Artificial Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Artificial Blood Products Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Artificial Blood Products Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Applications
  • Military
  • Civil
Companies covered
  • SpheriTech Ltd.
  • NuvOx Pharma
  • KaloCyte Inc.
  • HEMARINA SA
  • HbO2 Therapeutics
  • Aurum Biosciences Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Blood Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Blood Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Artificial Blood Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Artificial Blood Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Artificial Blood Products Market Dynamics
  1. 2.1 Artificial Blood Products Industry Trends
  2. 2.2 Artificial Blood Products Industry Drivers
  3. 2.3 Artificial Blood Products Industry Opportunities and Challenges
  4. 2.4 Artificial Blood Products Industry Restraints
3 Artificial Blood Products Market by Manufacturers
  1. 3.1 Global Artificial Blood Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Artificial Blood Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global Artificial Blood Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Artificial Blood Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artificial Blood Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Artificial Blood Products Manufacturers, Product Type & Application
  7. 3.7 Global Artificial Blood Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artificial Blood Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artificial Blood Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artificial Blood Products Tier 1, Tier 2, and Tier 3
4 Artificial Blood Products Market by Type
  1. 4.1 Artificial Blood Products Type Introduction
  2. 4.1.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
  3. 4.1.2 Hemoglobin-based Oxygen Carrier (HBOC)
  4. 4.2 Global Artificial Blood Products Sales by Type
  5. 4.2.1 Global Artificial Blood Products Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artificial Blood Products Sales by Type (2021-2032)
  7. 4.2.3 Global Artificial Blood Products Sales Market Share by Type (2021-2032)
  8. 4.3 Global Artificial Blood Products Revenue by Type
  9. 4.3.1 Global Artificial Blood Products Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Artificial Blood Products Revenue by Type (2021-2032)
  11. 4.3.3 Global Artificial Blood Products Revenue Market Share by Type (2021-2032)
5 Artificial Blood Products Market by Application
  1. 5.1 Artificial Blood Products Application Introduction
  2. 5.1.1 Military
  3. 5.1.2 Civil
  4. 5.2 Global Artificial Blood Products Sales by Application
  5. 5.2.1 Global Artificial Blood Products Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Artificial Blood Products Sales by Application (2021-2032)
  7. 5.2.3 Global Artificial Blood Products Sales Market Share by Application (2021-2032)
  8. 5.3 Global Artificial Blood Products Revenue by Application
  9. 5.3.1 Global Artificial Blood Products Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Artificial Blood Products Revenue by Application (2021-2032)
  11. 5.3.3 Global Artificial Blood Products Revenue Market Share by Application (2021-2032)
6 Global Artificial Blood Products Sales by Region
  1. 6.1 Global Artificial Blood Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Blood Products Sales by Region (2021-2032)
  3. 6.2.1 Global Artificial Blood Products Sales by Region (2021-2026)
  4. 6.2.2 Global Artificial Blood Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Artificial Blood Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Artificial Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Artificial Blood Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Artificial Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Artificial Blood Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Artificial Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Artificial Blood Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Artificial Blood Products Revenue by Region
  1. 7.1 Global Artificial Blood Products Revenue by Region
  2. 7.1.1 Global Artificial Blood Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Artificial Blood Products Revenue by Region (2021-2026)
  4. 7.1.3 Global Artificial Blood Products Revenue by Region (2027-2032)
  5. 7.1.4 Global Artificial Blood Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Artificial Blood Products Revenue (2021-2032)
  8. 7.2.2 North America Artificial Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Artificial Blood Products Revenue (2021-2032)
  11. 7.3.2 Europe Artificial Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Artificial Blood Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Artificial Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Artificial Blood Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Artificial Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 SpheriTech Ltd.
  2. 8.1.1 SpheriTech Ltd. Company Information
  3. 8.1.2 SpheriTech Ltd. Business Overview
  4. 8.1.3 SpheriTech Ltd. Artificial Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SpheriTech Ltd. Artificial Blood Products Product Portfolio
  6. 8.1.5 SpheriTech Ltd. Recent Developments
  7. 8.2 NuvOx Pharma
  8. 8.2.1 NuvOx Pharma Company Information
  9. 8.2.2 NuvOx Pharma Business Overview
  10. 8.2.3 NuvOx Pharma Artificial Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NuvOx Pharma Artificial Blood Products Product Portfolio
  12. 8.2.5 NuvOx Pharma Recent Developments
  13. 8.3 KaloCyte Inc.
  14. 8.3.1 KaloCyte Inc. Company Information
  15. 8.3.2 KaloCyte Inc. Business Overview
  16. 8.3.3 KaloCyte Inc. Artificial Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 KaloCyte Inc. Artificial Blood Products Product Portfolio
  18. 8.3.5 KaloCyte Inc. Recent Developments
  19. 8.4 HEMARINA SA
  20. 8.4.1 HEMARINA SA Company Information
  21. 8.4.2 HEMARINA SA Business Overview
  22. 8.4.3 HEMARINA SA Artificial Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HEMARINA SA Artificial Blood Products Product Portfolio
  24. 8.4.5 HEMARINA SA Recent Developments
  25. 8.5 HbO2 Therapeutics
  26. 8.5.1 HbO2 Therapeutics Company Information
  27. 8.5.2 HbO2 Therapeutics Business Overview
  28. 8.5.3 HbO2 Therapeutics Artificial Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HbO2 Therapeutics Artificial Blood Products Product Portfolio
  30. 8.5.5 HbO2 Therapeutics Recent Developments
  31. 8.6 Aurum Biosciences Ltd.
  32. 8.6.1 Aurum Biosciences Ltd. Company Information
  33. 8.6.2 Aurum Biosciences Ltd. Business Overview
  34. 8.6.3 Aurum Biosciences Ltd. Artificial Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio
  36. 8.6.5 Aurum Biosciences Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artificial Blood Products Value Chain Analysis
  2. 9.1.1 Artificial Blood Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artificial Blood Products Production Mode & Process
  6. 9.2 Artificial Blood Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artificial Blood Products Distributors
  9. 9.2.3 Artificial Blood Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst